Narrow Your Search

Narrow Your Search

Focus

Publisher

Companies

People

Articles

6,610 Articles
Psychedelics Today
Psychedelics Today
/
Apr 12, 2024

Updates from MAPS: Current Initiatives, Psychedelic Science 2024, and Music as a Bridge

In this episode, Joe interviews Devon Phillips: Community & Partnerships officer for the Multidisciplinary Association for Psychedelic Studies (MAPS). Phillips works on strategies to tackle the questions: How do we responsibly mainstream psychedelics? And how do we get culture engaged? He’s...
Psychedelic Invest
Psychedelic Invest
/
Apr 12, 2024

Red Light Holland’s Largest Psilocybin Shipment Received by CCrest Labs in Montreal with Health Canada Approved Import Permit

Toronto, Ontario–(Newsfile Corp. – April 12, 2024) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland” or the “Company”), a company engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and...
Psilocybin
Psychedelic Invest
Psychedelic Invest
/
Apr 12, 2024

Testing Psilocybin as a Treatment for Alcohol Use Disorder

The University of Calgary’s Hotchkiss Brain Institute is poised to launch an innovative clinical trial investigating the use of psilocybin in treating alcohol use disorder (AUD). This trial, involving 128 participants diagnosed with AUD, integrates psychedelic therapy with structured talk-therapy...
Psilocybin
Zen Habits
Zen Habits
/
Apr 12, 2024

Honoring Your Word to Yourself

By Leo Babauta There is a power to our word that is very often underdeveloped — words are magic, and can create the world around us. But most of us use this magic as if it weren’t powerful. The first way we see this is that we often don’t honor our word to ourselves. In his wonderful book, The...
Psychedelic Invest
Psychedelic Invest
/
Apr 12, 2024

The EU’s Plan for a €6.5M Study of Psychedelics To Treat Mental Disorders

At the recent launch of PsyPal, the first EU-funded clinical research project focused on psychedelic-assisted mental health treatments, MEPs were informed about the innovative strides being made in the field. The project, supported by a €6.5 million grant from Horizon Europe, seeks to explore the...
Psychedelics
Psychedelic Invest
Psychedelic Invest
/
Apr 12, 2024

All About the New Ketamine Trial at the University of Otago

Depression remains one of the most challenging mental health conditions, affecting millions worldwide with varying degrees of severity. Traditional treatments like psychotherapy and antidepressants are effective for many, yet a subset of patients find these methods inadequate. This has led to a...
Ketamine
Psychedelic Invest
Psychedelic Invest
/
Apr 12, 2024

Exploring Psilocybin’s Potential in Diabetes Management

Diabetes, a chronic condition marked by elevated blood sugar levels, is projected to affect over 700 million people globally by 2045. As the prevalence of diabetes continues to rise, researchers are investigating novel approaches to combat its effects. One such approach involves psilocybin, the...
Psilocybin
Psychedelic Invest
Psychedelic Invest
/
Apr 12, 2024

Indiana Advances Psilocybin Research with New Funding Initiative

Governor Eric Holcomb of Indiana has recently enacted a law that earmarks funds for clinical trials to explore the therapeutic effects of psilocybin. This development is part of a broader healthcare legislation that was modified to include provisions on psychedelic research, reflecting a growing...
Psilocybin MDMA
Psychedelic Invest
Psychedelic Invest
/
Apr 12, 2024

There’s a New Way To Measure the Potency of Magic Mushrooms

A collaborative effort among scientists from the University of Texas at Arlington, Scottsdale Research Institute in Phoenix, Shimadzu Scientific Instruments in Maryland, and Millipore-Sigma in Round Rock, Texas, has led to the development of a new method for quantifying the potency of psilocybin and...
Psilocybin
DoubleBlind Mag
DoubleBlind Mag
/
Apr 11, 2024

Ancient Romans Used to Trip on Hallucinogenic Seeds, Archeologists Say

Archaeologists just found evidence showing that ancient Romans had an affinity for plant medicine. In February, scientists in the Netherlands discovered an ancient Roman settler’s stash of hallucinogenic seeds located inside a hollowed-out animal bone dating back 2,000 years, Science reported. The...
Reality Sandwich
Reality Sandwich
/
Apr 11, 2024

Hapé: Roots and Rituals of Ceremonial Snuff

Intention: To learn about the ancient and spiritual use of ceremonial snuff, and understand how to incorporate it into ritual practices. In today’s world, there’s a growing fascination with practices that bridge the gap between the spiritual and the tangible. One such tradition, which has been...
Psychedelic Invest
Psychedelic Invest
/
Apr 11, 2024

Algernon Pharmaceuticals CEO Christopher J. Moreau to Be Featured on Radius Research’s Pitch, Deep Dive and Q&A Webinar on April 16th, 2024

VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to invite investors and other interested parties to participate in an upcoming special CEO interview and Q...
DMT
Psychedelics Today
Psychedelics Today
/
Apr 11, 2024

Navigating Psychedelics for Clinicians and Wellness Practitioners: LIVE

Join us for our upcoming course, Navigating Psychedelics, designed specifically for clinicians and wellness practitioners. This live course will provide you with the knowledge and tools necessary to safely and effectively integrate psychedelics into your practice. With a focus on current research...
Psychedelics
Psychedelic Invest
Psychedelic Invest
/
Apr 11, 2024

PharmAla Announces Private Placement and Concurrent Debt Settlement

VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class...
MDMA
Psychedelics Today
Psychedelics Today
/
Apr 11, 2024

What is Holding Space: Guiding Psychedelic Journeys and Creating Ideal Set and Setting

Much like the psychedelic experience itself, the idea of ‘spaceholding’ or ‘holding space’ can strike some as a nebulous concept. The term is largely synonymous with psychedelic facilitation or ceremony leading. When executed poorly, or not considered at all, the consequences can be severe...
Psychedelics - Green Market Report
Psychedelics - Green Market Report
/
Apr 10, 2024

Synaptogenix increases psilocybin stake with PsygaBio

Biopharmaceutical company Synaptogenix, Inc. (Nasdaq: SNPX) has increased its stake in the psilocybin drug discovery company PsygaBio through its previously announced partnership with Cannasoul Analytics. Synaptogenix had taken a 25% stake in Cannasoul in November of 2023 to support research and...
Psilocybin
Psychedelic Invest
Psychedelic Invest
/
Apr 10, 2024

Cybin to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic treatment options, is pleased to announce that Doug Drysdale,...
DMT
Psychedelic Invest
Psychedelic Invest
/
Apr 10, 2024

Silo Pharma set to Acquire Exclusive Licensing for Promising Alzheimer’s Disease Therapeutic

SARASOTA, FL, April 10, 2024 (GLOBE NEWSWIRE) —  Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today...
MAPS
MAPS
/
Apr 10, 2024
Psychedelic Invest
Psychedelic Invest
/
Apr 10, 2024

Seaport Therapeutics Launches with $100 Million Oversubscribed Series a Financing Round to Advance Novel Neuropsychiatric Medicines

BOSTON – Seaport Therapeutics, a clinical-stage biopharmaceutical company that is charting a proven path in neuropsychiatry, today announced the closing of a $100 million oversubscribed Series A financing round. The round was co-led by ARCH Venture Partners and Sofinnova Investments along...
DoubleBlind Mag
DoubleBlind Mag
/
Apr 10, 2024

Encyclopedia of the Amazon

The Matsés preserve an extraordinary amount of ecological knowledge, given the size of their population. There are approximately 2,500 Matsés in the Peruvian Amazon, and 1,300 across the Javari River in Brazil, but their territory is more than 3,800 square miles. Like many Indigenous communities...
Psychedelics - Green Market Report
Psychedelics - Green Market Report
/
Apr 10, 2024

Canada’s Optimi Health to ship psilocybin to New Zealand psychedelics research center

Canadian psychedelics company Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) inked a deal to supply a New Zealand research institute with psilocybin, giving the company a boost to its international dealings. Although Optimi already has a psychedelic footprint in neighboring Australia,...
Psilocybin
Reality Sandwich
Reality Sandwich
/
Apr 10, 2024

Green Noise: Nature’s Soothing Sound for Relaxation and Focus

Intention: To explore the frequency and intensity of ‘green noise’ and understand how to incorporate its soothing effects into one’s environment.  Green noise has emerged as a popular and effective tool for promoting relaxation, improving sleep, and enhancing focus. This unique type of sound,...
Psychedelics - Green Market Report
Psychedelics - Green Market Report
/
Apr 10, 2024

Colorado Legislature takes up psychedelic medicines regulation – again

Although Colorado voters approved a groundbreaking psychedelics legalization ballot measure in 2022, it’s still being implemented by lawmakers, who introduced yet another bill introduced at the state capitol to set the stage for a medical psilocybin industry. However, the legislative session will...
DoubleBlind Mag
DoubleBlind Mag
/
Apr 10, 2024

Best Movies To Watch On Acid

LSD inspires many people to venture outside, exploring the great-wide wonders of the Earth. But, every once in a while, you may want to plop down on a couch and let the trip come to you. Yet beware the Netflix paradox: 4,000 movies and nothing to watch! Fret not, for we have assembled a guide to...
LSD
Psychedelic Invest
Psychedelic Invest
/
Apr 10, 2024

Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders

Vancouver, Canada, April 10, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “company”), a clinical- stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health...
MAPS
MAPS
/
Apr 10, 2024
Psychedelic Invest
Psychedelic Invest
/
Apr 09, 2024

Numinus to Host Q2 Fiscal 2024 Results Conference Call on April 15, 2024

VANCOUVER, BC, April 9, 2024 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative behavioural health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, will...
Psychedelic Invest
Psychedelic Invest
/
Apr 09, 2024

Optimi Health Signs Psilocybin Supply Agreement With New Zealand-Based Mātai Medical Research Institute

VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as natural psilocybin and MDMA, is proud to announce the...
Psilocybin MDMA
Psilocybin Alpha
Psilocybin Alpha
/
Apr 09, 2024

Natural Medicine Advisory Bulletin 10.1: Legislative Update

Written by the Vicente LLP team as part of our Colorado Natural Medicine Health Act Tracker. On April 4, 2024, the Colorado General Assembly introduced Senate Bill 24-198, the first legislative update since the passing of SB 23-290 in 2023, which implemented the Natural Medicine Health Act. This...
Psychedelic Invest
Psychedelic Invest
/
Apr 09, 2024

Red Light Holland Launches Its Largest Psilocybin Shipment to Canada with Health Canada Approved Import Permit; Debenture Offering Successfully Closed

Toronto, Ontario–(Newsfile Corp. – April 9, 2024) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland” or the “Company”), a company engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe...
Psilocybin